Improving guideline‐concordant thromboprophylaxis prescribing for children admitted to hospital with COVID‐19

The incidence of venous thrombo‐embolism (VTE) in hospitalized children has increased by 130%–200% over the last two decades. Given this increase, many centers utilize electronic clinical decision support (CDS) to prognosticate VTE risk and recommend prophylaxis. SARS‐CoV‐2 infection (COVID‐19) is a risk factor for VTE; however, CDS developed before the COVID‐19 pandemic may not accurately prognosticate VTE risk in children with COVID‐19. This study's objective was to identify areas to improve thromboprophylaxis recommendations for children with COVID‐19.